|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Diakos CI, Charles KA, McMillan DC and
Clarke SJ: Cancer-related inflammation and treatment effectiveness.
Lancet Oncol. 15:e493–e503. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Inagaki N, Kibata K, Tamaki T, Shimizu T
and Nomura S: Prognostic impact of the mean platelet
volume/platelet count ratio in terms of survival in advanced
non-small cell lung cancer. Lung Cancer. 83:97–101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Takeuchi H, Abe M, Takumi Y, Hashimoto T,
Kobayashi R, Osoegawa A, Miyawaki M, Okamoto T and Sugio K: The
prognostic impact of the platelet distribution width-to-platelet
count ratio in patients with breast cancer. PLoS One.
12(e0189166)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
An X, Ding PR, Li YH, Wang FH, Shi YX,
Wang ZQ, He YJ, Xu RH and Jiang WQ: Elevated neutrophil to
lymphocyte ratio predicts survival in advanced pancreatic cancer.
Biomarkers. 15:516–522. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murakami Y, Saito H, Shimizu S, Kono Y,
Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y and Fujiwara Y:
Neutrophil-to-lymphocyte ratio as a prognostic indicator in
patients with unresectable gastric cancer. Anticancer Res.
39:2583–2589. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ishizuka M, Nagata H, Takagi K, Iwasaki Y
and Kubota K: Combination of platelet count and neutrophil to
lymphocyte ratio is a useful predictor of postoperative survival in
patients with colorectal cancer. Br J Cancer. 109:401–407.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Stojkovic Lalosevic M, Pavlovic Markovic
A, Stankovic S, Stojkovic M, Dimitrijevic I, Radoman Vujacic I,
Lalic D, Milovanovic T, Dumic I and Krivokapic Z: Combined
diagnostic efficacy of neutrophil-to-lymphocyte ratio (NLR),
platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV)
as biomarkers of systemic inflammation in the diagnosis of
colorectal cancer. Dis Markers. 2019(6036979)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Milasiene V, Stratilatovas E, Norkiene V
and Jonusauskaite R: Lymphocyte subsets in peripheral blood as
prognostic factors in colorectal cancer. J Buon. 10:261–264.
2005.PubMed/NCBI
|
|
11
|
Ozawa T, Ishihara S, Kawai K, Kazama S,
Yamaguchi H, Sunami E, Kitayama J and Watanabe T: Impact of a
lymphocyte to monocyte ratio in stage IV colorectal cancer. J Sur
Res. 199:386–392. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Choi WJ, Cleghorn MC, Jiang H, Jackson TD,
Okrainec A and Quereshy FA: Preoperative neutrophil-to-lymphocyte
ratio is a better prognostic serum biomarker than
platelet-to-lymphocyte ratio in patients undergoing resection for
nonmetastatic colorectal cancer. Ann Surg Oncol. 22 (Suppl
3):S603–S613. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Song Y, Yang Y, Gao P, Chen X, Yu D, Xu Y,
Zhao J and Wang Z: The preoperative neutrophil to lymphocyte ratio
is a superior indicator of prognosis compared with other
inflammatory biomarkers in resectable colorectal cancer. BMC
Cancer. 17(744)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Malietzis G, Giacometti M, Kennedy RH,
Athanasiou T, Aziz O and Jenkins JT: The emerging role of
neutrophil to lymphocyte ratio in determining colorectal cancer
treatment outcomes: A systematic review and meta-analysis. Ann Surg
Oncol. 21:3938–3946. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li MX, Liu XM, Zhang XF, Zhang JF, Wang
WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L and Lv Y: Prognostic role
of neutrophil-to-lymphocyte ratio in colorectal cancer: A
systematic review and meta-analysis. Int J Cancer. 134:2403–2413.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li H, Zhao Y and Zheng F: Prognostic
significance of elevated preoperative neutrophil-to-lymphocyte
ratio for patients with colorectal cancer undergoing curative
surgery: A meta-analysis. Medicine (Baltimore).
98(e14126)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chu-Yuan H, Jing P, Yi-Sheng W, He-Ping P,
Hui Y, Chu-Xiong Z, Guo-Jian L and Guo-Qiang W: The impact of
chemotherapy-associated neutrophil/lymphocyte counts on prognosis
of adjuvant chemotherapy in colorectal cancer. BMC Cancer.
13(177)2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Santullo F, Biondi A, Cananzi FCM, Fico V,
Tirelli F, Ricci R, Rizzo G, Coco C, Mattana C, D'Ugo D, et al:
Tumor size as a prognostic factor in patients with stage IIa colon
cancer. Am J Surg. 15:71–77. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
McShane LM, Altman DG, Sauerbrei W, Taube
SE, Gion M and Clark GM: Reporting recommendations for tumor marker
prognostic studies (remark). J Natl Cancer Inst. 97:1180–1184.
2005.PubMed/NCBI
|
|
20
|
Guo D, Han A, Jing W, Chen D, Jin F, Li M,
Kong L and Yu J: Preoperative to postoperative change in
neutrophil-to-lymphocyte ratio predict survival in colorectal
cancer patients. Future Oncol. 14:1187–1196. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sargent DJ, Wieand HS, Haller DG, Gray R,
Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ,
Francini G, et al: Disease-free survival versus overall survival as
a primary end point for adjuvant colon cancer studies: Individual
patient data from 20,898 patients on 18 randomized trials. J Clin
Oncol. 23:8664–8670. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xing X, Guo J, Wen X, Ding G, Li B, Dong
B, Feng Q, Li S, Zhang J, Cheng X, et al: Analysis of PD1, PDL1,
PDL2 expression and T cells infiltration in 1014 gastric cancer
patients. Oncoimmunology. 7(e1356144)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Malietzis G, Giacometti M, Askari A,
Nachiappan S, Kennedy RH, Faiz OD, Aziz O and Jenkins JT: A
preoperative neutrophil to lymphocyte ratio of 3 predicts
disease-free survival after curative elective colorectal cancer
surgery. Ann Surg. 260:287–292. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ozdemir Y, Akin ML, Sucullu I, Balta AZ
and Yucel E: Pretreatment neutrophil/lymphocyte ratio as a
prognostic aid in colorectal cancer. Asian Pacific J Cancer Prev.
15:2647–2650. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shibutani M, Maeda K, Nagahara H, Noda E,
Ohtani H, Nishiguchi Y and Hirakawa K: A high preoperative
neutrophil-to-lymphocyte ratio is associated with poor survival in
patients with colorectal cancer. Anticancer Res. 33:3291–3294.
2013.PubMed/NCBI
|
|
26
|
Coffelt SB, Wellenstein MD and de Visser
KE: Neutrophils in cancer: Neutral no more. Nat Rev Cancer.
16:431–446. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Crusz SM and Balkwill FR: Inflammation and
cancer: Advances and new agents. Nat Rev Clin Oncol. 12:584–596.
2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang X, Hu F, Li G, Li G, Yang X, Liu L,
Zhang R, Zhang B and Feng Y: Human colorectal cancer-derived
mesenchymal stem cells promote colorectal cancer progression
through IL-6/JAK2/STAT3 signaling. Cell Death Dis.
9(25)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhai J, Shen J, Xie G, Wu J, He M, Gao L,
Zhang Y, Yao X and Shen L: Cancer-associated fibroblasts-derived
IL-8 mediates resistance to cisplatin in human gastric cancer.
Cancer Lett. 454:37–43. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hu Z, Ding J, Ma Z, Sun R, Seoane JA,
Scott Shaffer J, Suarez CJ, Berghoff AS, Cremolini C, Falcone A, et
al: Quantitative evidence for early metastatic seeding in
colorectal cancer. Nat Genet. 51:1113–1122. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Guthrie GJ, Roxburgh CS, Farhan-Alanie OM,
Horgan PG and McMillan DC: Comparison of the prognostic value of
longitudinal measurements of systemic inflammation in patients
undergoing curative resection of colorectal cancer. Br J Cancer.
109:24–28. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Min KW, Kwon MJ, Kim DH, Son BK, Kim EK,
Oh YH and Wi YC: Persistent elevation of postoperative
neutrophil-to-lymphocyte ratio: A better predictor of survival in
gastric cancer than elevated preoperative neutrophil-to-lymphocyte
ratio. Sci Rep. 7(13967)2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu
L and Chen M: Postoperative neutrophil-to-lymphocyte ratio change
predicts survival of patients with small hepatocellular carcinoma
undergoing radiofrequency ablation. PLoS One.
8(e58184)2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ohno Y, Nakashima J, Ohori M, Gondo T,
Hatano T and Tachibana M: Followup of neutrophil-to-lymphocyte
ratio and recurrence of clear cell renal cell carcinoma. J Urol.
187:411–417. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li Z, Zhao R, Cui Y, Zhou Y and Wu X: The
dynamic change of neutrophil to lymphocyte ratio can predict
clinical outcome in stage I-III colon cancer. Sci Rep.
8(9453)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Reiche EM, Nunes SO and Morimoto HK:
Stress, depression, the immune system, and cancer. Lancet Oncol.
5:617–625. 2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fukakusa M, Bergeron C, Tulic MK, Fiset
PO, Al Dewachi O, Laviolette M, Hamid Q and Chakir J: Oral
corticosteroids decrease eosinophil and CC chemokine expression but
increase neutrophil, IL-8, and IFN-gamma-inducible protein 10
expression in asthmatic airway mucosa. J Allergy Clin Immunol.
115:280–286. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yoshino T, Cleary JM, Van Cutsem E, Mayer
RJ, Ohtsu A, Shinozaki E, Falcone A, Yamazaki K, Nishina T,
Garcia-Carbonero R, et al: Neutropenia and survival outcomes in
metastatic colorectal cancer patients treated with
trifluridine/tipiracil in the RECOURSE and J003 trials. Ann Oncol.
31:88–95. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wu J, Ge XX, Zhu W, Zhi Q, Xu MD, Duan W,
Chen K, Gong FR, Tao M, Shou LM, et al: Values of applying white
blood cell counts in the prognostic evaluation of resectable
colorectal cancer. Mol Med Rep. 19:2330–2340. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lin GN, Liu PP, Liu DY, Peng JW, Xiao JJ
and Xia ZJ: Prognostic significance of the pre-chemotherapy
lymphocyte-to-monocyte ratio in patients with previously untreated
metastatic colorectal cancer receiving FOLFOX chemotherapy. Chin J
Cancer. 35(5)2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lin JX, Wang ZK, Huang YQ, Xie JW, Wang
JB, Lu J, Chen QY, Lin M, Tu RH, Huang ZN, et al: Dynamic
changes in pre- and postoperative levels of inflammatory markers
and their effects on the prognosis of patients with gastric cancer.
J Gastrointest Surg: Feb 3, 2020 (Epub ahead of print).
|
|
43
|
Miyatani K, Saito H, Kono Y, Murakami Y,
Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K and Fujiwara
Y: Combined analysis of the pre- and postoperative
neutrophil-lymphocyte ratio predicts the outcomes of patients with
gastric cancer. Surg Today. 48:300–307. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yamamoto M, Saito H, Uejima C, Tanio A,
Takaya S, Ashida K and Fujiwara Y: Combined pre- and postoperative
lymphocyte count accurately predicts outcomes of patients with
colorectal cancer. Dig Surg. 36:487–494. 2019.PubMed/NCBI View Article : Google Scholar
|
